|
1
|
Hong QY, Wu GM, Qian GS, Hu CP, Zhou JY,
Chen LA, Li WM, Li SY, Wang K, Wang Q, et al Lung Cancer Group of
Chinese Thoracic Society; Chinese Alliance Against Lung Cancer, :
Prevention and management of lung cancer in China. Cancer. 121
(Suppl 17):2957–3088. 2015. View Article : Google Scholar
|
|
2
|
Torre LA, Siegel RL and Jemal A: Lung
Cancer Statistics. Adv Exp Med Biol. 893:1–19. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhao Y and Adjei AA: New strategies to
develop new medications for lung cancer and metastasis. Cancer
Metastasis Rev. 34:265–275. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chang A: Chemotherapy, chemoresistance and
the changing treatment landscape for NSCLC. Lung Cancer. 71:3–10.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gonzalez PS, OPrey J, Cardaci S, Barthet
VJA, Sakamaki JI, Beaumatin F, Roseweir A, Gay DM, Mackay G,
Malviya G, et al: Mannose impairs tumour growth and enhances
chemotherapy. Nature. 563:719–723. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hu C, Zhang M, Moses N, Hu CL, Polin L,
Chen W, Jang H, Heyza J, Malysa A, Caruso JA, et al: The
USP10-HDAC6 axis confers cisplatin resistance in non-small cell
lung cancer lacking wild-type p53. Cell Death Dis. 11:3282020.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nevel KS, DiStefano N, Lin X, Skakodub A,
Ogilvie SQ, Reiner AS, Pentsova E and Boire A: A retrospective,
quantitative assessment of disease burden in patients with
leptomeningeal metastases from non-small-cell lung cancer. Neuro
Oncol. 22:675–683. 2019. View Article : Google Scholar
|
|
8
|
Fu QF, Liu Y, Fan Y, Hua SN, Qu HY, Dong
SW, Li RL, Zhao MY, Zhen Y, Yu XL, et al: Alpha-enolase promotes
cell glycolysis, growth, migration, and invasion in non-small cell
lung cancer through FAK-mediated PI3K/AKT pathway. J Hematol Oncol.
8:222015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fong Y, Wu CY, Chang KF, Chen BH, Chou WJ,
Tseng CH, Chen YC, Wang HD, Chen YL and Chiu CC: Dual roles of
extracellular signal-regulated kinase (ERK) in quinoline compound
BPIQ-induced apoptosis and anti-migration of human non-small cell
lung cancer cells. Cancer Cell Int. 17:372017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang H, Yu Z, Huo S, Chen Z, Ou Z, Mai J,
Ding S and Zhang J: Overexpression of ELF3 facilitates cell growth
and metastasis through PI3K/Akt and ERK signaling pathways in
non-small cell lung cancer. Int J Biochem Cell Biol. 94:98–106.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li T, Dong ZR, Guo ZY, Wang CH, Zhi XT,
Zhou JW, Li DK, Chen ZT, Chen ZQ and Hu SY: Mannose-mediated
inhibitory effects of PA-MSHA on invasion and metastasis of
hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway. Liver
Int. 35:1416–1429. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sturge J, Todd SK, Kogianni G, McCarthy A
and Isacke CM: Mannose receptor regulation of macrophage cell
migration. J Leukoc Biol. 82:585–593. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ding D, Yao Y, Yang C and Zhang S:
Identification of mannose receptor and CD163 as novel biomarkers
for colorectal cancer. Cancer Biomark. 21:689–700. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dent P: Crosstalk between ERK, AKT, and
cell survival. Cancer Biol Ther. 15:245–246. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nathanson L: Malignant Melanoma: Biology
Diagnosis, and Therapy. Springer US; Boston, MA: 1988, View Article : Google Scholar
|
|
16
|
Chung LY, Tang SJ, Sun GH, Chou TY, Yeh
TS, Yu SL and Sun KH: Galectin-1 promotes lung cancer progression
and chemoresistance by upregulating p38 MAPK, ERK, and
cyclooxygenase-2. Clin Cancer Res. 18:4037–4047. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang H, Wang D, Li C, Zhang X, Zhou X and
Huang J: High Kpnβ1 expression promotes non-small cell lung cancer
proliferation and chemoresistance via the PI3-kinase/AKT pathway.
Tissue Cell. 51:39–48. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fumarola C, Bonelli MA, Petronini PG and
Alfieri RR: Targeting PI3K/AKT/mTOR pathway in non small cell lung
cancer. Biochem Pharmacol. 90:197–207. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vansteenkiste JF, Canon JL, De Braud F,
Grossi F, De Pas T, Gray JE, Su WC, Felip E, Yoshioka H, Gridelli
C, et al: Safety and efficacy of buparlisib (BKM120) in patients
with PI3K pathway-activated non-small cell lung cancer: Results
from the phase II BASALT-1 study. J Thorac Oncol. 10:1319–1327.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tolcher AW, Khan K, Ong M, Banerji U,
Papadimitrakopoulou V, Gandara DR, Patnaik A, Baird RD, Olmos D,
Garrett CR, et al: Antitumor activity in RAS-driven tumors by
blocking AKT and MEK. Clin Cancer Res. 21:739–748. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Deutsch E, Le Péchoux C, Faivre L, Rivera
S, Tao Y, Pignon JP, Angokai M, Bahleda R, Deandreis D, Angevin E,
et al: Phase I trial of everolimus in combination with thoracic
radiotherapy in non-small-cell lung cancer. Ann Oncol.
26:1223–1229. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Blumenschein GR Jr, Gatzemeier U, Fossella
F, Stewart DJ, Cupit L, Cihon F, OLeary J and Reck M: Phase II,
multicenter, uncontrolled trial of single-agent sorafenib in
patients with relapsed or refractory, advanced non-small-cell lung
cancer. J Clin Oncol. 27:4274–4280. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cairns RA, Harris IS and Mak TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
de la Fuente M and Hernanz A: Enzymes of
mannose metabolism in murine and human lymphocytic leukaemia. Br J
Cancer. 58:567–569. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cazet A, Charest J, Bennett DC, Sambrooks
CL and Contessa JN: Mannose phosphate isomerase regulates
fibroblast growth factor receptor family signaling and glioma
radiosensitivity. PLoS One. 9:e1103452014. View Article : Google Scholar : PubMed/NCBI
|
